• Severson R, Nomura A, Grove J et al. A prospective study of demographics diet and prostate cáncer among men of Japanese
• ancestry in Hawaii. Cáncer Res 49(7):1857-1860, April 1989
• Shamberger R, Frost D. Possible protective effect of selenium against human cáncer. Can Med Assoc J. 100(14):682, 1969 Shamberger R. Relationship of selenium to cáncer, I: inhibitory effect of selenium on carcinogenesis. Journal of the National
• Cáncer Institute 44(4): 931-936,1970.
• Shamberger R, Tytko S, Willis C. Antioxidants and cáncer, part IV: selenium and age-adjusted human cáncer mortality. Archives
• of Environmental Health 31(5): 231-235, 1976
• Sharma A, Goldberg M, Cerimele B. Pharmacokinetcis and safety of Duloxetine a dual-serotonin and norepinephrine reuptake
• inhibitor. J Clin Pharmacol 40:161-167,2000
• Shen J, Klein R, Wei Q. Low-dose genistein induces cyclin-dependent kinase inhibitors and G(1) cell-cycle arrest in human
• prostate cáncer cell. Mol Carcinog 29(2):92-102, 2000
• Shin H et al. Prostatic intraepithelial neoplasía: a potential precursor lesion of prostatic adenocarcinoma. Yonsei Med J 36(3): 215-31 Jul 1995
• Shirai T, Asamoto M, Takahashi S. Diet and prostate cáncer. Toxicology 181-182:89-94, 2002
• Shoskes D, Zeitlin S, Shahed A et al. Quercetin in men with category III chronic Prostatitis. A preliminary prospective, double
• blind, placebo-controlled trial. Urology 54:960-963,1999
• Shoskes D. Phytotherapy in chronic prostatitis. Urology. 60(6 Suppl):35-37, Dec 2002
• Shimizu H, Ross R, Bernstein L. Cáncers of the prostate and breast among Japanese and white immigrants in Los Angeles County.
• British Journal of Cáncer 63(6): 963-966, Junio 1991.
• Sinha A, Gleason D, Stanley N et al. Cathepsin B in angiogenesis of Human prostate: an immunohistochemical and
• immunoelectron microscopic analysis. Anat Rec 241(3): 353-62 Mar 1995.
• Sinha R, Rothman N, Brown E et al. High concentrations of the carcinogen 2-amino-1-methyl-6 phenylimidazo- [4,5-b]pyridine
• (PhIP) occur in chicken but are dependent on the cooking method. Cáncer Res. 15;55(20):4516-4519, Oct 1995
• Smith D, Bullock A et al. Racial Differences in a Prostate Cáncer Screening Study. Journal Urol 156, 1366-1369, Oct 1996. Smith C et al. Botulinum toxin A: physiologic and clinical effects on the lower urinary tract. J Urol 165: suppl:37 abstract, 2001 Small E et al. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cáncer. J Clin Oncol
• 18:3595-3603, 2000
• Sokeland K. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasía: analysis of
• prostate volume and therapeutic outcome. BJU International 86: 439-442, 2000
• Spiegel H. Nocebo: the power of suggestibility. Prevent Med 26(5):616-621,1997
• Spiegel D. Health Caring. Psychosocial support for patients with cáncer. Cáncer 74, 1453-1457, 1994.
• Spiegel D et al. Effect of psychosocial treatment on survival of patients with metastasíc breast cáncer. Lancet 2; 888-891, 1989
• Spiegel D, Bloom J,Yalom I. Group support for patients with metastasíc cáncer. Archives of General Psychiatry 38, 527-533, 1981
• Steers WD,Chai TC, Gray ML. The incidence of a positive ice water test in bladder outlet obstructed patients: evidence for bladder
• neural plasticity. J Urol. 160(1):34-38, Jul 1998
• Steers WD, Tuttle JB. Mechanisms of Disease: the role of nerve growth factor in the pathophysiology of bladder disorders. Nat Clin
• Pract Urol. 3(2):101-110, Feb 2006
• Steele V et al. Lipooxygenase inhibitors as potential cáncer chemopreventives.Cáncer Epid Biomarkers Prev 8:467-83, Mayo 1999
• Steinberg G, Carter B et al. Family history and the risk of prostate cáncer. The Prostate 17(1): 337-347, 1990.
• Steiner M et al. Selective estrogen receptor modulators for the chemoprevention of prostate cáncer. Urology 57:68-72, April 2001
• Steinmetz K, Potter J. Vegetables, fruit, and cáncer prevention: a review. J Am Diet Assoc 96:1027-1039, 1996
• Steinmetz K, Potter J. Vegetables, fruit and cáncer. I Epidemiology. Cáncer Causes Control 2:325-357,1991
• Steinmetz KA, Potter JD. Vegetables, fruit and Cáncer. II Mechanisms cáncer Causes Control 2:427-442,1991
• Stephens F. Phytoestrogens and prostate cáncer: Possible preventive role. Medical Journal of Australia 167:138-140,1997.
• Srilatha B, Adaikan P. Estrogen and phytoestrogen predispose to erectile dysfunction: do ER-alpha and ER-beta in the cavernosum
• play a role? Urology 63(2):382-386, 2004.
• Subbaramaiah K, Dannenberg A. Cyclooxygenase 2: a molecular target for cáncer prevention and treatment. Trends in
• Pharmacological Sciences, 24:2:96-102, 2003
• Sugimura T. Carcinogenesis.Nutrition and dietary carcinogens. Carcinogenesis, 21(3): 387-395, March 2000
• Sun Y, MaLossi J, Jacobs SC, Chai TC. Effect of doxazosin on stretch-activated adenosine triphosphate release in bladder urothelial
• cells from patients with benign prostatic hyperplasía. Urology. 60(2):351-356, Aug 2002
• Susuki T et al. Clinical effect of Cernilton in chronic prostatitis. Hynyokika Kiyo-Acta Urol Jap 38:489-494,1992 Schwartz G et al. Human prostate cáncer cells: Inhibition of proliferation by vitamin D analogs. Antic Res 14:1077-1082,1994. Schulz V et al. Rational Phytotherapy: A Physicians' Guide to Herbal Medicine. 3 ed. Berlin, Germany: Springer-Verlag 231, 1998. Strum S. New Developments in Prostate cáncer treatment. PCR Insigth 4(4):3 Oct 2001 http://www. prostate- cáncer. org/
• resource/pdf/Is4-4.pdf
• Szabó C. Multiple pathways of peroxynitrite cytotoxicity. Toxicology Letters, 140-141:1:105-112, 2003
• Takao T, Tsujimura A, Fujita K, et al. Inhibitory effect of tamsulosin on normal human prostate epithelial and stromal cells.
• Abstract # 1337. J Urol 171(4):352, May 2004
• Takao T, Tsujimura A et al.Inhibitory effect of tamsulosin on normal human prostate epithelial and stromal cells. BPH & Male LUTS
• Selected Abstracts.Confer Rep/AUA meeting San Francisco USA, Wednesday, 12 May 2004 http://www .urotoday. com/index. php?option= com_adv search Talpur N, Echard B, Bagchi D et al.Comparison of Saw Palmetto (extract and whole berry) and Cernitin on prostate growth in rats.
• Mol Cell Biochem. 250(1-2):21-26, Aug 2003
• Tammela T, Konturri M. Long-term effects of finasteride on invasíve urodynamics and symptoms in the treatment of patients with
• bladder outflow obstruction due to benign prostatic hyperplasía. Journal of Urology 154(4):1466-1469, 1995
• Tarasuk V et al. Interpreting Epidemiologic Studies of Diet-Disease Relationships. Journal of Nutrit 127 (9):1847-1852, Sep 1997 Tavani A, Longoni E, Bosetti C et al. Intake of selected micronutrients and the risk of surgically treated benign prostatic
• hyperplasía: a case-control study from Italy. Eur Urol 50:549-554, 2006
• Tavani A et al. Dietary intake of calcium, vitamin D, Phosphorus and the risk of prostate cáncer. Eur Urol 48:27-33, 2005 Teicher B. Response of the fibrosarcoma to antiangiogenic medlators plus cytotoxic agents Antic Research 13:2101-2106,1993 Teicher B. Potentiation of cytotoxic cáncer therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma
• Breast Cáncer Research Treat 36(2):227-236,1995
• Terry P, Lichtenstein P, Feychting M et al. Fatty Fish Consumption and risk of prostate cáncer. Lancet 357; 1764-1766,2001
• The Alpha-Tocopherol, Beta Carotene Cáncer Prevention Study Group: The effect of vitamin E and beta carotene on the incidence
• of lung cáncer and other cáncers in male smokers N Eng J Med 330:1029-1035,1994.
• The Virginia Prostate Center- Virginia Prostate Center Newsletter 2(2)-Fall 1997. Cáncer Prevention may be linked to diet.
• http://www. evms.edu /vpc/ newsletter/ 1997-fall. html#Prevention
• Thompson I, Lucia M et al. Finasteride decreases the risk of prostatic intraepithelial neoplasía. J Urol.178(1):107-109, Jul 2007 Thompson I et al. Chemoprevention of prostate cáncer: the Prostate Cáncer Prevention Trial. The Prostate 33(3): 217-221, 1997.
• Thompson I, Lucia M, Redman M et al.Finasteride Decreases the Risk of Prostatic Intraepithelial Neoplasía. J Urol. 2007 May 10
• Thompson I, Goodman P, Tangen C et al.The influence of Finasteride on the development of prostate cáncer. N Engl J Med. 349(3):215-224, 17 Jul 2003
• Thompson I, Feigl P, Coltman C. Chemoprevention of prostate cáncer with Finasteride. In: De Vita V, Hellman S, Rosenberg S, eds. Important Advances in Oncology 1995. Philadelphia, Pa: JB. Lippincott Co.57-76, 1995
• Thompson I et al. The Prostate Cáncer Prevention Trial. Current status and lessons learned.Urology 57 (Suppl 4A): 230-234, 2001
• Thompson I, Ankerst D, Chi C et al. Assessing prostate cáncer risk: results from the Prostate Cáncer Prevention Trial (PCPT). Journal National Cáncer Institute 98(8):529-534, 19 April 2006
• Thompson I, Klein E, Lippman S, et al. Prevention of Prostate cáncer with finasteride: US/European perspective. European Urology 44:650-655,2003.
• Thompson I et al. First International Conference on Chemoprev of prostate cáncer. J Urol 171(2) part 2 of 2: S3-S4, Feb 2004
• Thompson I et al. The influence of Finasteride on the development of Prostate Cáncer. N Eng J Med 349:213-222,2003.